Delivery Order SPE2DB20D2014-SPE2DB24FB94J
- Not listed
- This federal contract award is for the delivery of Repatha 140 mg/ml SureClick medication to the Defense Logistics Agency (DLA). The $7,167.57 firm-fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award is for the delivery of Repatha 140 mg/ml SureClick medication, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,454.48 firm-fixed-price delivery order has a completion date of January 25, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range...
- This federal contract award is for the delivery of Repatha 140 mg/ml SureClick medication to the Defense Logistics Agency (DLA). The $1,016.82 firm fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Amerisourcebergen holds a...
- This federal contract award is for the delivery of Repatha 140 mg/mL SureClick pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $1,041.42 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 6, 2025, with a completion date of May 7, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a substantial $999,999,999.00 Indefinite...
- This federal contract award is for the delivery of Repatha 140 mg/mL Sureclick medication to the Defense Logistics Agency (DLA). The $14,150.40 fixed-price contract was awarded on March 29, 2022 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as...
- This federal contract award is for the delivery of Repatha, a 140 mg/mL sureClickTM injectable medication, to the Defense Logistics Agency (DLA). The $1,267.50 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of July 18, 2024 and is not designated with a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,570.68 firm fixed-price delivery order is for the supply of Repatha 140 mg/mL SureClick medication. The contract has an ultimate completion date of December 9, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award is for the delivery of Repatha 140 mg/ml Sureclick medication to the Defense Logistics Agency (DLA). The $10,111.23 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of April 25, 2023. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award is for the delivery of Repatha 140 mg/ml SureClick, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,500.19 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has a period of performance through November 3, 2023 and does not include any set-aside designation, indicating full and open competition. Amerisourcebergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,300.77 firm fixed-price delivery order is for the supply of Repatha 140 mg/ml SureClick medication. The contract has an ultimate completion date of May 7, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB94JDelivery Order
This federal contract award is for the delivery of Repatha 140 mg/ml SureClick medication to the Defense Logistics Agency (DLA), a major logistics agency supporting the U.S. Department of Defense. The $3,828.00 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 20, 2024 with a completion date of May 21, 2024. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to the DLA worldwide. The current $3,828.00 delivery order is part of this larger IDC, which enables the DLA to efficiently procure essential medical commodities for military treatment programs and facilities globally. AmerisourceBergen also holds a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 5/20/24 |